Medindia

X

AFFiRiS AG: VACCINATION AGAINST HYPERTENSION IS DEVELOPMENT PROJECT NO. 4 AND HAS ALREADY BEEN AWARDED AN FFG GRANT OF UP TO EUR 1.2 MILLION.

Thursday, February 25, 2010 Research News J E 4
Advertisement
Vienna, 25 February 2010. With immediate effect AFFiRiS AG is starting a development program for vaccination against hypertension. For this project the Austrian Research Promotion Agency (FFG) is providing development funds of up to EUR 1.2 million. With today's announcement four of the current seven vaccine projects of AFFiRiS AG are in the public domain. As with the other vaccines under development – to treat Alzheimer's disease, Parkinson's disease and atherosclerosis – the new vaccine will be based on the company's own AFFITOME® technology. However, for the first time it is now being used against a human hormone. The reason for this announcement is the gratifying approval of significant development funds by the Austrian Research Promotion Agency, FFG.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Toys"R"Us, U.S. Launches Fundraising Campaign to H...
S
New York State Department of Health, Legacy and Ad...